Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

[Image: see text]

Detalles Bibliográficos
Autores principales: McCue, Maggie, Sarkey, Sara, Eramo, Anna, François, Clement, Parikh, Sagar V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178841/
https://www.ncbi.nlm.nih.gov/pubmed/35676662
http://dx.doi.org/10.1186/s12888-022-03975-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178841/
https://www.ncbi.nlm.nih.gov/pubmed/35676662
http://dx.doi.org/10.1186/s12888-022-03975-3

Ejemplares similares